drugset / Trial / NCT06969326

Topical Estrogen: Brief Intervention to Improve Postoperative Experience for Transgender Men Undergoing Hysterectomy

NCT06969326

Phase 3 Recruiting 48 enrolled Women and Infants Hospital of Rhode Island
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to determine if applying a single dose of topical estrogen cream in the operating room at the end of your hysterectomy (removal of uterus and cervix) improves the postoperative experience with bleeding and potential symptoms of dysphoria (a feeling of discomfort or distress). Topical estrogen cream is sometimes used if patients have increased risk of bleeding with surgery but is not currently utilized in a consistent way. This study aims to answer the question of whether this is a helpful treatment and should be included in standard postoperative care.

Timeline

Start
2025-05-01
Primary completion
2026-09-01
Completion
2026-12-01

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Estradiol Other / unclassified 2 g Topical

Indications

No indication recorded.